BioNTech SE (NAS:BNTX)
$ 116.85 -3.97 (-3.29%) Market Cap: 28.97 Bil Enterprise Value: 10.93 Bil PE Ratio: 0 PB Ratio: 1.37 GF Score: 66/100

BioNTech SE at JPMorgan Healthcare Conference Transcript

Jan 11, 2022 / 02:45PM GMT
Release Date Price: $215.8 (-6.17%)
Cory William Kasimov
JPMorgan Chase & Co, Research Division - Senior Biotechnology Analyst

Great. Good morning or good afternoon from the 40th Annual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap biotech analyst. And it's my pleasure to introduce BioNTech and CEO, Ugur Sahin, who really needs no introduction. (Operator Instructions).

Thanks so much for joining us today. Let me turn things over to you for an update.

Ugur Sahin
BioNTech SE - Co-Founder, CEO & Member of Management Board

So thank you, Cory. Thank you for the introduction and invitation to present at the conference. Good morning, good afternoon, and thank you to everyone listening to our presentation today. In my presentation, I'm going to start with a recap of 2021 and the historic impact BioNTech had on [June half]. I will then highlight our multi-platform strategy and diversified pipeline. And I will close with a review of our outlook for the coming years. After my presentation, I will be joined by other members of our management team for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot